Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 750,342 | 611,657 | 577,752 | 778,624 | 824,356 |
| Marketable Securities | N/A | N/A | N/A | 127,321 | 115,863 |
| Receivables | 314,114 | 339,304 | 315,465 | 285,843 | 282,131 |
| Inventories | 34,594 | 31,833 | 33,728 | 34,716 | 35,797 |
| Other current assets | 230,352 | 220,892 | 197,478 | 190,803 | 243,170 |
| TOTAL | $1,389,280 | $1,285,799 | $1,194,417 | $1,468,655 | $1,551,738 |
| Non-Current Assets | |||||
| PPE Net | 472,663 | 476,113 | 479,109 | 477,686 | 481,492 |
| Investments And Advances | 73,757 | 86,304 | 89,267 | 117,901 | 127,973 |
| Intangibles | 937,083 | 941,661 | 967,722 | 553,096 | 560,801 |
| Other Non-Current Assets | 356,253 | 368,725 | 379,413 | 356,297 | 322,724 |
| TOTAL | $1,839,756 | $1,872,803 | $1,915,511 | $1,504,980 | $1,492,990 |
| Total Assets | $3,229,036 | $3,158,602 | $3,109,928 | $2,973,635 | $3,044,728 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,288 | 11,550 | 17,380 | 16,413 | 19,727 |
| Accrued Expenses | 376,498 | 360,915 | 347,529 | 280,611 | 362,883 |
| Other current liabilities | 39,615 | 37,111 | 31,644 | 32,650 | 37,702 |
| TOTAL | $457,485 | $441,877 | $417,836 | $354,536 | $442,902 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 188,099 | 199,449 | 204,903 | 170,456 | 163,755 |
| TOTAL | $188,532 | $199,697 | $205,199 | $171,667 | $164,139 |
| Total Liabilities | $646,017 | $641,574 | $623,035 | $526,203 | $607,041 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,066 | 96,377 | 95,436 | 95,348 | 95,835 |
| Common Shares | 95 | 95 | 94 | 94 | 94 |
| Retained earnings | 2,601,552 | 2,543,413 | 2,496,255 | 2,462,928 | 2,449,876 |
| Other shareholders' equity | -18,628 | -26,480 | -9,456 | -15,590 | -12,283 |
| TOTAL | $2,583,019 | $2,517,028 | $2,486,893 | $2,447,432 | $2,437,687 |
| Total Liabilities And Equity | $3,229,036 | $3,158,602 | $3,109,928 | $2,973,635 | $3,044,728 |